VSBCOTCServices-Commercial Physical & Biological ResearchFiscal year ends January 31
VITASPRING BIOMEDICAL CO. LTD.
Financials through Q2 FY2027, quarter ended Jul 31, 2026Last filing: 10-Q on Sep 17, 2026
$0.03+0.00 (0.00%)
Close on Oct 19, 2026
- Market cap
- $6.58M
- P/E (TTM)
- –
- Dividend yield
- –
Dividends
Vitaspring Biomedical has not reported a dividend
No dividend per share appears in Vitaspring Biomedical's annual filings since fiscal 2017.